Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: fewer (74), minus (30), excluding (249)

InP-MATRix

Description: Chemotherapy Protocol LYMPHOMA MATRix – CYTARABINE-METHOTREXATE-RITUXIMAB-THIOTEPA Inpatient Regimen Regimen • Lymphoma – InP-M
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-MATRix.pdf

Bendamustine-Obinutuzumab

Description: Chemotherapy Protocol Non-Hodgkin Lymphoma Bendamustine-Obinutuzumab Regimen • NHL – Bendamustine-Obinutuzumab Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Obinutuzumab.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Mye
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

Pulmonary vein isolation radiofrequency ablation - patient information

Description: Patient information factsheet Pulmonary vein isolation (PVI) ablation Your doctor has recommended you have the above proc
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Pulmonaryveinisolationradiofrequencyablation-725-PIL.pdf

VenetoclaxLow

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

InP-Etoposide-Ifosfamide (3 day) v2

Description: Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (3 day) Inpatient Regimen Regimen • Sarcoma-InP-Etoposide-Ifosfamide (3 da
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Etoposide-Ifosfamide-3-day-v2.pdf

Selinexor Bortezomib Dexamethasone

Description: Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf

Cyclophosphamide Docetaxel Epirubicin (100) Fluorouracil Pertuzumab Trastuzumab FE100CT-HP

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACILPERTUZUMAB-TRASTUZUMAB (FE10
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil-Pertuzumab-Trastuzumab-FE100CT-HP.pdf

Carboplatin-Docetaxel-Trastuzumab

Description: Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL-TRASTUZUMAB (TCH) Regimen • Breast Cancer – Ca
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Trastuzumab.pdf

Capecitabine-Cisplatin-Trastuzumab

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE-CISPLATIN-TRASTUZUMAB Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Trastuzumab.pdf

241 to 250 of 1000

Previous … 23 24 25 26 27 … Next